H.C. Wainwright starts coverage of Sight Sciences stock with USD 14.00 target

Published on 10/16/2026 at 04:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 23.39 million for the period ended June 30, 2026. The next earnings date for Sight Sciences stock is November 5, 2026.

Coverage, results and next date

H.C. Wainwright initiated coverage with a USD 14.00 target on October 15, 2026.
Sight Sciences reported USD 23.39 million in second-quarter revenue and adjusted earnings per share of minus USD 0.08 on August 5, 2026.
Sight Sciences is scheduled to report third-quarter results on November 5, 2026.

SGHT, US82657M1053, Illustration mit AI erstellt.

Sight Sciences (ISIN US82657M1053) received a new USD 14.00 price target from H.C. Wainwright on October 15, 2026, after the brokerage initiated coverage with a Buy rating. Markets Insider reported that the firm sees two commercial growth platforms and improving operating leverage.

What does USD 14.00 mean?

The target is USD 14.00, while Sight Sciences last stood at USD 8.80 on October 15, 2026 at 4:00 p.m. ET on Nasdaq. The difference is 59.09 percent, calculated against that last price, although the target and the market quotation use the same US dollar basis.

The company is developing interventional products for glaucoma and dry eye treatment. Its OMNI Ultra system became commercially available on October 1, 2026, with the launch centered on canaloplasty followed by trabeculotomy through a single corneal incision, according to GlobeNewswire.

Three dated company steps

On August 5, 2026, Sight Sciences reported second-quarter revenue of USD 23.39 million and adjusted earnings per share of minus USD 0.08, versus a consensus loss of USD 0.16, according to Nasdaq. On October 1, 2026, the company announced OMNI Ultra commercial availability through GlobeNewswire. On October 15, 2026, H.C. Wainwright initiated coverage and set the USD 14.00 target through Markets Insider.

When are the next results?

Sight Sciences is scheduled to report third-quarter 2026 results on November 5, 2026, after the market closes, according to Nasdaq. The company reported total assets of USD 104.87 million at June 30, 2026, while operating cash flow for the second quarter was negative USD 5.66 million.

Stock valuation and timing

The USD 14.00 target places the analyst view well above the latest Nasdaq quotation of USD 8.80, while the second-quarter revenue comparison shows a business still operating at a loss. The next results will provide the next dated test of revenue execution and operating leverage.

The last available home-market quotation was USD 8.80 at 4:00 p.m. ET on October 15, 2026, on Nasdaq. The further course of trading is shown by the real-time quote of Sight Sciences stock.